Role of Neuron-Specific Enolase in the Diagnosis and Disease Monitoring of Sarcoidosis

Table 4

Likelyhood of oral corticosteroid use based on serum ACE, sIL-2R, and NSE in sarcoidosis.

Parameter	Cutoff value	No. of OCS-treated cases/OCS-untreated cases	Odds ratio	95% CI	value
ACE () vs. ACE ()	21.4	10/36 vs. 8/58	2.01	0.78–5.73	0.198
	14.5	14/74 vs. 4/20	0.95	0.30–2.87	>0.999
sIL-2R () vs. sIL-2R (−)	482	15/70 vs. 3/13	0.93	0.23–3.37	>0.999
	581	15/57 vs. 3/26	2.28	0.66–7.89	0.262
NSE () vs. NSE (−)	12.0	14/43 vs. 4/51	4.15	1.25–12.13	0.019

OCS: oral corticosteroid; CI: confidence interval.